# FDG PET-CT in Advanced Breast Cancer

> **NCT07173868** · — · RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Histologically Confirmed Metastatic or Locally Advanced Breast Cancer With no Radical Topical Treatment Available
- If There is Liver Metastasis, Which the Researcher Believes Will be Difficult to Evaluate the Response Accurately With Bone Metastasis or CT

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07173868
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-25
- **Primary completion:** 2025-12-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07173868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07173868, "FDG PET-CT in Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07173868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*